Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023

• Autori principali: Yihan Yang (Autore), Sheng Wei (Autore), Huan Tian (Autore), Jing Cheng (Autore), Yue Zhong (Autore), Xiaoling Zhong (Autore), Dunbing Huang (Autore), Cai Jiang (Autore), Xiaohua Ke (Autore)
• Natura: Libro
• Pubblicazione: Frontiers Media S.A., 2024-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

BackgroundDonepezil in combination with memantine is a widely used clinical therapy for moderate to severe dementia. However, real-world population data on the long-term safety of donepezil in combination with memantine are incomplete and variable. Therefore, the aim of this study was to analyze the...